MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to ...

Moderna stock has fallen over the past four years, but shares got a boost on positive comments about AI. Is MRNA stock a buy ...

Moderna shares closed up Thursday gaining momentum following recent comments by Oracle Chairman Larry Ellison about the role of artificial intelligence in revolutionizing cancer treatment.

The S&P 500 gained 0.5% on Thursday, Jan. 23, reaching a record close as President Donald Trump pressed for lower oil prices ...

Oracle founder Larry Ellison said the Stargate project, a joint venture with OpenAI and Softbank, will help to fuel the ...

OpenAI and SoftBank (SFTBY) will commit $19B each to the artificial intelligence-focused Stargate Project, The Information ...

Bryan Johnson highlights Larry Ellison's views on AI revolutionizing healthcare, particularly in cancer detection, treatment, ...

Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 12,155 calls trading, 1.0x expected, and implied vol increasing almost 2 ...

The former venture capital arm of Binance will become the family office of CZ and Binance co-founder Yi He, Bloomberg reported.

As 2024 was drawing to a close, OpenAI CEO Sam Altman faced two major problems. He wasn’t getting enough server capacity from Microsoft, his company’s biggest backer, to stay ahead of rivals ...

Stocks closed solidly higher on Thursday for the fourth straight session as investor optimism about the Trump administration continues to run high.

Robby Soave and Niall Stanage weigh in on debate of using A.I. to develop mRNA vaccines to target cancer. #AI #mrnavaccines ...